Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucolipidosis type IV.

G Bach1

  • 1Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem 91120, Israel. Bach@hadassah.org.il

Molecular Genetics and Metabolism
|July 20, 2001
PubMed
Summary
This summary is machine-generated.

Mucolipidosis type IV (MLIV) is a rare genetic disorder affecting Ashkenazi Jews, causing neurodegeneration and vision problems. Researchers identified the MCOLN1 gene and specific mutations linked to MLIV, aiding in diagnosis and prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency.

Neuroscience·2007
Same author

Bioactive hydroxyphenylpyrrole-dicarboxylic acids from a new marine Halomonas sp.: Production and structure elucidation.

Applied microbiology and biotechnology·2006
Same author

Genomic organisation of the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) and its mutations in mucolipidosis III.

Journal of medical genetics·2004
Same author

Mucolipidosis III type C: first-trimester biochemical and molecular prenatal diagnosis.

Prenatal diagnosis·2003
Same author

[Prevention of inherited disorders: carrier screening, its benefits and potential harm].

Harefuah·2002
Same author

Mucolipidosis IV: novel mutation and diverse ultrastructural spectrum in the skin.

Neuropediatrics·2002
Same journal

Accessibility and harmonization of biochemical tests for diagnosis and monitoring of Porphyrias in the United States: Recommendations by members of the American Porphyrias Expert Collaborative (APEX).

Molecular genetics and metabolism·2026
Same journal

Participants with long-chain 3-hydroxy-acylCoA dehydrogenase deficiency (LCHADD)/trifunctional protein deficiency (TFPD) report consistent low-fat diet intake over time.

Molecular genetics and metabolism·2026
Same journal

Expanding the clinical and molecular spectrum of NGLY1 deficiency: A multicenter cohort.

Molecular genetics and metabolism·2026
Same journal

Driving treatment for females with X-linked adrenoleukodystrophy.

Molecular genetics and metabolism·2026
Same journal

High dietary fat causes muscle structural breakdown, mitochondrial dysfunction, and contractile deficits in the absence of carnitine palmitoyltransferase 2.

Molecular genetics and metabolism·2026
Same journal

Ketogenic diet therapy in pyruvate dehydrogenase deficiency: Global clinical practice from literature and survey data.

Molecular genetics and metabolism·2026
See all related articles

Area of Science:

  • Genetics and Molecular Biology
  • Neuroscience
  • Ophthalmology

Background:

  • Mucolipidosis type IV (MLIV) is a lysosomal storage disorder with neurodegenerative and ophthalmological symptoms.
  • It disproportionately affects individuals of Ashkenazi Jewish descent, with a high carrier frequency.
  • MLIV results from defects in endocytosis and lysosomal trafficking.

Purpose of the Study:

  • To identify the genetic basis of Mucolipidosis type IV.
  • To characterize the mutations in the MLIV gene and their correlation with disease phenotype.
  • To investigate the functional role of the MCOLN1 gene product in cellular processes.

Main Methods:

  • Gene mapping to chromosome 19p13.2-13.3 and identification of the MCOLN1 gene.
  • Mutation analysis in MLIV patients, including sequencing and deletion detection.

Related Experiment Videos

  • Functional studies on the MCOLN1 protein, mucolipin 1, including homology and domain analysis.

    • Main Results:

    • The MCOLN1 gene was identified as the causative gene for MLIV.
    • Two common mutations account for 95% of MLIV alleles in Ashkenazi Jews: an splice-site mutation and a partial gene deletion.
    • Mucolipin 1, the protein encoded by MCOLN1, is a transmembrane protein homologous to calcium channels, likely involved in endocytosis.
    • A population screening program for MLIV heterozygotes has been initiated in Israel.

    Conclusions:

    • Mutations in the MCOLN1 gene are the primary cause of Mucolipidosis type IV.
    • Understanding the genetic basis and mutation spectrum facilitates carrier screening and genetic counseling.
    • Mucolipin 1's role in endocytosis suggests potential therapeutic targets for MLIV and related disorders.